-
Eltanexor: From Nuclear Export to CRC Strategy
2026-09-15
Eltanexor (KPT-8602) offers translational researchers a way to interrogate XPO1 biology across hematologic malignancies and colorectal cancer. This thought-leadership analysis connects nuclear export inhibition with Wnt/β-catenin signaling, experimental design, and the practical decisions needed to move from pathway observation to credible preclinical evidence.
-
Biotin-HPDP and Microglial CD36 Palmitoylation
2026-09-15
A translational perspective on using reversible thiol labeling to interrogate the SELENOK–CD36 pathway, connect palmitoylation chemistry with microglial Aβ phagocytosis, and strengthen mechanistic evidence beyond conventional product-page claims.
-
Triamcinolone Research Workflow and QC Guide
2026-09-14
Triamcinolone is a defined synthetic glucocorticoid agonist for controlled in vitro studies of glucocorticoid signaling, inflammation, and immunosuppression. This guide addresses solvent selection, stock preparation, storage, and assay QC; the compound is for scientific research only and not for diagnostic, therapeutic, or medical use.
-
5-Aminolevulinic Acid HCl as a Heme Pathway Probe
2026-09-14
Explore how 5-Aminolevulinic acid HCl can function as a mechanistic probe of tetrapyrrole metabolism rather than merely a pathway intermediate. This article connects the compound’s biochemical properties to Salmonella haem-driven immune evasion, assay design, photodynamic research, and cancer research.
-
Protease Inhibitor Cocktail EDTA-Free: Lab Workflow
2026-09-13
Protease Inhibitor Cocktail EDTA-Free helps limit endogenous proteolysis during protein extraction and sample preparation for applications such as Western blotting, co-immunoprecipitation, pull-down assays, and phosphorylation analysis. Its EDTA-free formulation is appropriate for divalent-cation-sensitive workflows, but it should not be treated as a substitute for a separately validated chelation strategy when metalloprotease inhibition is required.
-
Preserving Phosphorylation for Translational Precision
2026-09-12
Phosphorylation data are only as reliable as the workflow that preserves them. This thought-leadership article connects phosphatase control to the SGI-1027–everolimus study in renal cancer and provides practical guidance for building more reproducible translational assays.
-
Diminazene Aceturate Research Workflows
2026-09-12
Diminazene Aceturate supports both trypanosome parasite research and mechanism-led ACE2 activation research. This practical guide covers stock preparation, assay design, mitochondrial readouts, controls, and troubleshooting while separating established findings from workflow recommendations.
-
Dasatinib: A Causal Assay Map for Kinase Biology
2026-09-11
Dasatinib (BMS-354825) is more than a Src/Bcr-Abl inhibitor: it can serve as a disciplined perturbation tool for separating kinase-dependent phenotypes from SNAI1-driven tumor-state programs. This guide connects kinase assays, EMT measurements, and the PIK3R2/p-EphA2 findings in thymic epithelial tumors.
-
Cholecystokinin octapeptide ammonium: Research Workflow
2026-09-11
Build more reproducible CCK-8 experiments with a workflow that connects receptor pharmacology to B-cell immunoglobulin output, neuronal apoptosis, and cardiac ANP signaling. Practical guidance covers dose selection, salt handling, pathway controls, and troubleshooting for this context-dependent peptide.
-
QPRT Drives Breast Cancer Invasion via PLC–MLC Signaling
2026-09-10
Liu et al. show that elevated quinolinate phosphoribosyltransferase (QPRT) promotes breast cancer migration and invasion through a signaling axis linked to purinergic receptors, Rho/ROCK, phospholipase C, and myosin light chain phosphorylation. The study connects altered NAD+ metabolism with cytoskeletal remodeling and provides a pharmacological framework for testing PLC-dependent mechanisms in invasive breast cancer models.
-
Azilsartan B2210 for Reliable Cell Assays
2026-09-10
Azilsartan (TAK-536, SKU B2210) offers a controlled AT1-receptor perturbation for cell viability, inflammation, and astrocyte–microglia experiments. This scenario-based guide explains solvent compatibility, assay controls, interpretation of metabolic readouts, and practical criteria for selecting a reliable research-grade material.
-
Alda 1: ALDH2 Activator for Cardiac Research
2026-09-09
Alda 1 enables genotype-aware studies of ALDH2, aldehyde detoxification, and cardiomyocyte proliferation, with applications spanning biochemical assays and cardiac stress models. Its research value is strongest when enzymatic rescue, cellular proliferation, and functional cardiac endpoints are measured as separate stages rather than treated as interchangeable outcomes.
-
Angiotensin 1/2 (5-7): RAS Research Guide
2026-09-09
Angiotensin 1/2 (5-7) is the H2N-Ile-His-Pro-OH peptide fragment used in renin-angiotensin system research. The A1049 material has a reported molecular weight of 365.43 Da, HPLC and mass-spectrometry purity of 98.36%, and documented activity in SARS-CoV-2 spike–receptor binding assays.
-
Anlotinib Hydrochloride: From Kinase Biology to Translation
2026-09-08
Anlotinib hydrochloride offers a translational framework for studying tumor angiogenesis through coordinated inhibition of VEGFR2, PDGFRβ, FGFR1, and downstream ERK signaling. This article connects mechanistic evidence with assay design, competitive benchmarking, pharmacokinetic interpretation, and practical strategy for cancer research teams.
-
Capsaicin as a KDM1A/LSD1 Inhibitor
2026-09-08
The reference study identified Capsaicin, also called (E)-Capsaicin, as a direct, reversible, FAD-competitive inhibitor of KDM1A/LSD1 with activity in gastric cancer cells. Its findings connect a familiar pungent natural product to histone-demethylase biology and provide a starting point for studying KDM1A-dependent epithelial–mesenchymal transition and tumor-cell invasion.